- Home
- MLYS vs BBAI Comparison
MLYS vs BBAI Comparison
Compare MLYS & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- BBAI
- Stock Information
- Founded
- MLYS 2019
- BBAI 2020
- Country
- MLYS United States
- BBAI United States
- Employees
- MLYS N/A
- BBAI N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- BBAI EDP Services
- Sector
- MLYS Health Care
- BBAI Technology
- Exchange
- MLYS Nasdaq
- BBAI Nasdaq
- Market Cap
- MLYS 893.0M
- BBAI 1.0B
- IPO Year
- MLYS 2023
- BBAI N/A
- Fundamental
- Price
- MLYS $14.66
- BBAI $3.03
- Analyst Decision
- MLYS Strong Buy
- BBAI Strong Buy
- Analyst Count
- MLYS 3
- BBAI 3
- Target Price
- MLYS $27.00
- BBAI $5.17
- AVG Volume (30 Days)
- MLYS 2.0M
- BBAI 43.8M
- Earning Date
- MLYS 05-08-2025
- BBAI 03-06-2025
- Dividend Yield
- MLYS N/A
- BBAI N/A
- EPS Growth
- MLYS N/A
- BBAI N/A
- EPS
- MLYS N/A
- BBAI N/A
- Revenue
- MLYS N/A
- BBAI $158,236,000.00
- Revenue This Year
- MLYS N/A
- BBAI $29.43
- Revenue Next Year
- MLYS N/A
- BBAI $24.51
- P/E Ratio
- MLYS N/A
- BBAI N/A
- Revenue Growth
- MLYS N/A
- BBAI 1.98
- 52 Week Low
- MLYS $8.24
- BBAI $1.17
- 52 Week High
- MLYS $18.38
- BBAI $10.36
- Technical
- Relative Strength Index (RSI)
- MLYS 56.01
- BBAI 36.51
- Support Level
- MLYS $16.15
- BBAI $2.85
- Resistance Level
- MLYS $17.21
- BBAI $3.83
- Average True Range (ATR)
- MLYS 1.30
- BBAI 0.27
- MACD
- MLYS -0.03
- BBAI 0.03
- Stochastic Oscillator
- MLYS 36.19
- BBAI 17.86
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.